Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.255 USD | +1.12% | +16.84% | -4.04% |
May. 30 | Sector Update: Health Care Stocks Higher in Afternoon Trading | MT |
May. 30 | Xeris Biopharma Says Potential Levothyroxine Injection Preferred Over Oral Formulation; Shares Rise | MT |
Financials (USD)
Sales 2024 * | 185M | Sales 2025 * | 219M | Capitalization | 334M |
---|---|---|---|---|---|
Net income 2024 * | -60M | Net income 2025 * | -30M | EV / Sales 2024 * | 1.81 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.52 x |
P/E ratio 2024 * |
-5.34
x | P/E ratio 2025 * |
-10.7
x | Employees | 377 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.09% |
Latest transcript on Xeris Biopharma Holdings, Inc.
1 day | +1.12% | ||
1 week | +16.84% | ||
1 month | +21.24% | ||
3 months | -29.09% | ||
6 months | +19.31% | ||
Current year | -4.04% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Edick
CEO | Chief Executive Officer | 67 | 21-04-30 |
Steven Pieper
DFI | Director of Finance/CFO | 47 | 21-09-30 |
John Shannon
PSD | President | 62 | 21-10-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Johnson
BRD | Director/Board Member | 66 | 21-10-04 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 21-10-04 |
Marla Persky
BRD | Director/Board Member | 68 | 21-10-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 1,487 M€ | +7.77% | - | |
0.00% | 9 M€ | +9.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.255 | +1.58% | 2,923,991 |
24-05-30 | 2.22 | +15.03% | 5,059,086 |
24-05-29 | 1.93 | +0.52% | 878,346 |
24-05-28 | 1.92 | -0.52% | 1,041,311 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.04% | 334M | |
+40.73% | 739B | |
+31.40% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.49% | 240B | |
+9.21% | 210B | |
-5.11% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- XERS Stock